Top Markets
#1 Black Phoenix Black Phoenix +824.20%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.37%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 Prom Prom +20.14%
#5 Magma Finance Magma Finance +19.82%
#6 SAFEcoin SAFEcoin +19.77%
#7 Beam Beam +18.79%
#8 pipedog pipedog +17.11%
#9 Bless Bless +17.08%
#10 YFSX YFSX +15.57%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Hisse Senetlerindeki Sıralama #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Hisse Fiyatı
$45.79
Piyasa Değeri
$2.33B
Değişim (1 gün)
11.43%
Değişim (1 yıl)
408.10%
Ülke
FR
Ticaret Nanobiotix S.A. (NANO)

Kategori

Healthcare
Nanobiotix S.A. (NANO) için kazanç
2026 itibarıyla kazanç TTM: 0
Nanobiotix S.A. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Nanobiotix S.A. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH